DexCom Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
88.36 M
Public Float
77.07 M
DexCom Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.47
Market Cap
$13.38 B
Shares Outstanding
91.05 M
Public Float
88.13 M

Profile

Address
6340 Sequence Drive
San Diego California 92121
United States
Employees -
Website http://www.dexcom.com
Updated 07/08/2019
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F.

Financials

View All
Created with Highcharts 5.0.14DexCom Inc.Net Income. Fiscal year is January-December. All values USD Thousands.29 80029 80022 40022 40057 60057 60065 60065 60050 20050 200127127201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14DexCom Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.160 000160 000259 200259 200402 000402 000573 300573 300718 500718 5001 0321 0322013201420152016201720180200k400k600k800k

Kevin Ronald Sayer
Chairman, President & Chief Executive Officer
Jay S. Skyler
Independent Director